Supernus INDV
NASDAQ INDV
$36.25 +0.88 (+2.49%)
At close: Nov 2, 2026 · 4:00 PM EST

Supernus (INDV) Asset Utilization Ratio (2025 - 2026)

Updated

Indivior Pharmaceuticals' (INDV) Asset Utilization Ratio was 1.07 for Q3 2026, up 30.1% from 0.82 a year earlier but down 2.3% from the prior quarter.

Analysis

Supernus (INDV) Asset Utilization Ratio (2025 - 2026) Analysis & Trends

For FY2025, Asset Utilization Ratio at Indivior Pharmaceuticals was 0.98, up 27.4% from FY2024.

  • By year, Asset Utilization Ratio came in at 0.77 in FY2024.
  • Five-year quarterly Asset Utilization Ratio spans a low of 0.82 in Q3 2025 and a high of 1.10 in Q2 2026.
  • Year over year, Asset Utilization Ratio has now increased in each of the last three quarters.
  • Per Business Quant data, the three quarters before Q3 2026 came in at 1.10 (Q2 2026), 1.08 (Q1 2026) and 0.95 (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Asset Util. (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn 0.60
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn 0.50
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn 0.47
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn 0.51
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn 0.45
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn 0.47
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn 0.41
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn 0.62
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn 0.31
10 Supernus 4.28 Bn 3.38 Bn 305.00 Mn 1.07
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 1.07
Jun 30, 2026 1.10
Mar 31, 2026 1.08
Dec 31, 2025 0.95
Sep 30, 2025 0.82
Jun 30, 2025 0.83
Mar 31, 2025 0.87
API Access

Supernus Asset Utilization Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=asset-utilization-ratio&ticker=INDV&period=max&api_key=YOUR_API_KEY